160 related articles for article (PubMed ID: 33979562)
1. Cost-Effectiveness of Four Financial Incentive Programs for Smoking Cessation.
Russell LB; Volpp KG; Kwong PL; Cosgriff BS; Harhay MO; Zhu J; Halpern SD
Ann Am Thorac Soc; 2021 Dec; 18(12):1997-2006. PubMed ID: 33979562
[No Abstract] [Full Text] [Related]
2. Incentives for smoking cessation.
Cahill K; Hartmann-Boyce J; Perera R
Cochrane Database Syst Rev; 2015 May; (5):CD004307. PubMed ID: 25983287
[TBL] [Abstract][Full Text] [Related]
3. The Economic Impact of Smoking and of Reducing Smoking Prevalence: Review of Evidence.
Ekpu VU; Brown AK
Tob Use Insights; 2015; 8():1-35. PubMed ID: 26242225
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness and cost-utility analysis of a work-place smoking cessation intervention with and without financial incentives.
van den Brand FA; Nagelhout GE; Winkens B; Chavannes NH; van Schayck OCP; Evers SMAA
Addiction; 2020 Mar; 115(3):534-545. PubMed ID: 31849138
[TBL] [Abstract][Full Text] [Related]
5. Randomized trial of four financial-incentive programs for smoking cessation.
Halpern SD; French B; Small DS; Saulsgiver K; Harhay MO; Audrain-McGovern J; Loewenstein G; Brennan TA; Asch DA; Volpp KG
N Engl J Med; 2015 May; 372(22):2108-17. PubMed ID: 25970009
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of financial incentives and disincentives for improving food purchases and health through the US Supplemental Nutrition Assistance Program (SNAP): A microsimulation study.
Mozaffarian D; Liu J; Sy S; Huang Y; Rehm C; Lee Y; Wilde P; Abrahams-Gessel S; de Souza Veiga Jardim T; Gaziano T; Micha R
PLoS Med; 2018 Oct; 15(10):e1002661. PubMed ID: 30278053
[TBL] [Abstract][Full Text] [Related]
7. Are financial incentives cost-effective to support smoking cessation during pregnancy?
Boyd KA; Briggs AH; Bauld L; Sinclair L; Tappin D
Addiction; 2016 Feb; 111(2):360-70. PubMed ID: 26370095
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness of enhancing a Quit-and-Win smoking cessation program for college students.
Popp J; Nyman JA; Luo X; Bengtson J; Lust K; An L; Ahluwalia JS; Thomas JL
Eur J Health Econ; 2018 Dec; 19(9):1319-1333. PubMed ID: 29687268
[TBL] [Abstract][Full Text] [Related]
9. Economic analysis of financial incentives for smoking cessation during pregnancy and postpartum.
Shepard DS; Slade EP; Nighbor TD; DeSarno MJ; Roemhildt ML; Williams RK; Higgins ST
Prev Med; 2022 Dec; 165(Pt B):107079. PubMed ID: 35533885
[TBL] [Abstract][Full Text] [Related]
10. 'Cut down to quit' with nicotine replacement therapies in smoking cessation: a systematic review of effectiveness and economic analysis.
Wang D; Connock M; Barton P; Fry-Smith A; Aveyard P; Moore D
Health Technol Assess; 2008 Feb; 12(2):iii-iv, ix-xi, 1-135. PubMed ID: 18093448
[TBL] [Abstract][Full Text] [Related]
11. Financial incentives for quitting smoking in pregnancy: Are they cost-effective?
McMeekin N; Sinclair L; Robinson-Smith L; Mitchell A; Bauld L; Tappin DM; Boyd KA
Addiction; 2023 Aug; 118(8):1445-1456. PubMed ID: 36843417
[TBL] [Abstract][Full Text] [Related]
12. Paying Low-Income Smokers to Quit? The Cost-Effectiveness of Incentivizing Tobacco Quit Line Engagement for Medicaid Recipients Who Smoke.
Mundt MP; Baker TB; Fraser DL; Smith SS; Piper ME; Fiore MC
Value Health; 2019 Feb; 22(2):177-184. PubMed ID: 30711062
[TBL] [Abstract][Full Text] [Related]
13. Encouraging smokers to quit: the cost effectiveness of reimbursing the costs of smoking cessation treatment.
Kaper J; Wagena EJ; van Schayck CP; Severens JL
Pharmacoeconomics; 2006; 24(5):453-64. PubMed ID: 16706571
[TBL] [Abstract][Full Text] [Related]
14. Healthcare financing systems for increasing the use of tobacco dependence treatment.
van den Brand FA; Nagelhout GE; Reda AA; Winkens B; Evers SMAA; Kotz D; van Schayck OC
Cochrane Database Syst Rev; 2017 Sep; 9(9):CD004305. PubMed ID: 28898403
[TBL] [Abstract][Full Text] [Related]
15. Heterogeneity in the Effects of Reward- and Deposit-based Financial Incentives on Smoking Cessation.
Halpern SD; French B; Small DS; Saulsgiver K; Harhay MO; Audrain-McGovern J; Loewenstein G; Asch DA; Volpp KG
Am J Respir Crit Care Med; 2016 Oct; 194(8):981-988. PubMed ID: 27064456
[TBL] [Abstract][Full Text] [Related]
16. Competitions and incentives for smoking cessation.
Cahill K; Perera R
Cochrane Database Syst Rev; 2011 Apr; (4):CD004307. PubMed ID: 21491388
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of motivational interviewing for smoking cessation and relapse prevention among low-income pregnant women: a randomized controlled trial.
Ruger JP; Weinstein MC; Hammond SK; Kearney MH; Emmons KM
Value Health; 2008; 11(2):191-8. PubMed ID: 17854434
[TBL] [Abstract][Full Text] [Related]
18. Perceptions of Financial Incentives for Smoking Cessation: A Survey of Smokers in a Country With an Endgame Goal.
Robertson L; Gendall P; Hoek J; Marsh L; McGee R
Nicotine Tob Res; 2018 Nov; 20(12):1481-1488. PubMed ID: 29253215
[TBL] [Abstract][Full Text] [Related]
19. Financial incentives to Medicaid smokers for engaging tobacco quit line treatment: maximising return on investment.
Mundt MP; Baker TB; Piper ME; Smith SS; Fraser DL; Fiore MC
Tob Control; 2020 May; 29(3):320-325. PubMed ID: 31147478
[TBL] [Abstract][Full Text] [Related]
20. The SmokingPaST Framework: illustrating the impact of quit attempts, quit methods, and new smokers on smoking prevalence, years of life saved, medical costs saved, programming costs, cost effectiveness, and return on investment.
O'Donnell MP; Roizen MF
Am J Health Promot; 2011; 26(1):e11-23. PubMed ID: 21879928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
